Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model. [electronic resource]
Producer: 19980107Description: 324-33 p. digitalISSN:- 0014-4886
- Animals
- Anterior Chamber
- Antioxidants -- administration & dosage
- Brain Tissue Transplantation
- Dopamine -- analysis
- Dose-Response Relationship, Drug
- Fetal Tissue Transplantation
- Graft Survival -- drug effects
- Mesencephalon -- cytology
- Nerve Fibers -- ultrastructure
- Neurons -- chemistry
- Parkinson Disease -- surgery
- Pregnatrienes -- administration & dosage
- Rats
- Rats, Sprague-Dawley
- Transplantation, Heterotopic
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.